No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Zhejiang Xianju Pharmaceutical Co.,Ltd. is a global enterprise specializing in the production and distribution of steroidal and hormonal pharmaceutical products. Its offerings span active pharmaceutical ingredients (APIs), specifically steroid-based medications and both male and female hormones, alongside various chemical intermediates. The company also provides a comprehensive selection of finished dosage forms, including tablets, capsules, granules, soft capsules, powder inhalations, creams, gels, injections, and powder-for-injection preparations. Established in 1972, Zhejiang Xianju Pharmaceutical Co.,Ltd. operates from its headquarters in Xianju, China.
www.xjpharma.comNo one on the platform currently holds 002332.SZ.
No tracked institution reports a position in 002332.SZ as of their last filing.
No one on the platform has traded 002332.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 8.0% | 13.2% | 11.3% | — | — | — |
| Rev. Growth % | -6.0% | -1.3% | ||||
| Profit Margin % | 12.0% | 13.4% | 11.2% | |||
| Free Cash Flow Margin % | 1.0% | 6.3% | 6.0% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $4.0B | +1.8% | $0.47 | $0.47–$0.48 | — | 2 |
| 2027 | $4.3B | +8.2% | $0.55 | $0.54–$0.56 | — | 2 |
| 2028 | $4.9B | +12.7% | $0.62 | $0.61–$0.63 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 002332.SZZhejiang Xianju Pharmaceutical Co.,Ltd. | $8.47 | -1.51% | $8.4B | — |
| 000739.SZApeloa Pharmaceutical Co.,Ltd | $22.76 | +1.74% | $26.4B | — |
| 002099.SZZhejiang Hisoar Pharmaceutical Co., Ltd. | $5.29 | -1.31% | $8.6B | — |
| 002262.SZJiangsu Nhwa Pharmaceutical Co., Ltd. | $21.52 | -0.60% | $21.9B | — |
| 002294.SZShenzhen Salubris Pharmaceuticals Co., Ltd. |
| $29.31 |
| -0.98% |
| $32.7B |
| — |
| 002317.SZGuangdong Zhongsheng Pharmaceutical Co., Ltd. | $24.69 | -0.44% | $21.0B | — |
| 002390.SZGuizhou Xinbang Pharmaceutical Co., Ltd. | $2.91 | +0.00% | $5.7B | — |
Source: Financial Modeling Prep · peers by sector/industry